Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: Age, mediastinal downstaging, and extent of pulmonary resection as independent predictors

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 1, 2011, Pages 48-58

  Paul, Subroto ^a   Mirza, Farooq ^a   Port, Jeffrey L ^a   Lee, Paul C ^a   Stiles, Brendon M ^a   Kansler, Amanda L ^a   Altorki, Nasser K ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

CI; computed tomography; confidence interval; CT; non small cell lung cancer; NSCLC; PET; positron emission tomography

Indexed keywords

PLATINUM; TAXANE DERIVATIVE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INDEPENDENT VARIABLE; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SAFETY; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODES; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650293751     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.07.092     Document Type: Article

References (30)

1. N. Martini, M.G. Kris, B.J. Flehinger, R.J. Gralla, M.S. Bains, and M.E. Burt Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1374
2. J.A. Roth, E.N. Atkinson, F. Fossella, R. Komaki, M. Bernadette Ryan, and J.B. Putnam Jr. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer Lung Cancer 21 1998 1 6
3. R. Rosell, J. Gómez-Codina, C. Camps, J. Javier Sánchez, J. Maestre, and J. Padilla Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial Lung Cancer 26 1999 7 14
4. J.L. Port, R.J. Korst, P.C. Lee, M.A. Levin, D.E. Becker, and R. Keresztes Surgical resection for residual N2 disease after induction chemotherapy Ann Thorac Surg 79 2005 1686 1690
5. R. Bueno, W.G. Richards, S.J. Swanson, M.T. Jaklitsch, J.M. Lukanich, and S.J. Mentzer Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival Ann Thorac Surg 70 2000 1826 1831
6. D.C. Betticher, S.F. Hsu Schmitz, M. Totsch, E. Hansen, C. Joss, and C. von Briel Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study Br J Cancer 94 2006 1099 1106
7. K.S. Albain, R.S. Swann, V.W. Rusch, A.T. Turrisi 3rd, F.A. Shepherd, and C. Smith Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
8. P. De Leyn, P. Schoonooghe, G. Deneffe, D. Van Raemdonck, W. Coosemans, and J. Vansteenkiste Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease) Eur J Cardiothorac Surg 10 1996 649 655
9. A. Depierre, B. Milleron, D. Moro-Sibilot, S. Chevret, E. Quoix, and B. Lebeau Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 2002 247 253
10. H. Decaluwé, P. De Leyn, J. Vansteenkiste, C. Dooms, D. Van Raemdonck, and P. Nafteux Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival Eur J Cardiothorac Surg 36 2009 433 439
11. D.W. Johnstone, R.W. Byhardt, D. Ettinger, and C.B. Scott Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 54 2002 365 369
12. P. Garrido, J.L. González-Larriba, A. Insa, M. Provencio, A. Torres, and D. Isla Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901 J Clin Oncol 25 2007 4736 4742
13. J. Martin, R.J. Ginsberg, A. Abolhoda, M.S. Bains, R.J. Downey, and R.J. Korst Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy Ann Thorac Surg 72 2001 1149 1154
14. M. Thomas, C. Rübe, P. Hoffknecht, H.N. Macha, L. Freitag, and A. Linder Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer Lancet Oncol 9 2008 636 648
15. J.P. van Meerbeeck, G.W. Kramer, P.E. Van Schil, C. Legrand, E.F. Smit, and F. Schramel Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 2007 442 450
16. P.A. Thomas Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy Eur J Cardiothorac Surg 36 2009 431 432
17. A. Stefani, M. Alifano, A. Bobbio, M. Grigoroiu, R. Jouni, and P. Magdeleinat Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients J Thorac Cardiovasc Surg 140 2010 356 363
18. W. Weder, S. Collaud, W.E. Eberhardt, S. Hillinger, S. Welter, and R. Stahel Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer J Thorac Cardiovasc Surg 139 2010 1424 1430
19. D.C. Betticher, S.F. Hsu Schmitz, M. Tötsch, E. Hansen, C. Joss, and C. von Briel Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759
20. W. Eberhardt, H. Wilke, G. Stamatis, M. Stuschke, A. Harstrick, and H. Menker Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial J Clin Oncol 16 1998 622 634
21. R.O. Dillman, S.L. Seagren, K.J. Propert, J. Guerra, W.L. Eaton, and M.C. Perry A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 940 945
22. R.O. Dillman, J. Herndon, S.L. Seagren, W.L. Eaton Jr., and M.R. Green Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
23. W.T. Sause, C. Scott, S. Taylor, D. Johnson, R. Livingston, and R. Komaki Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 1995 198 205
24. H.I. Pass, H.W. Pogrebniak, S.M. Steinberg, J. Mulshine, and J. Minna Randomized trial of neoadjuvant therapy for lung cancer: interim analysis Ann Thorac Surg 53 1992 992 998
25. K. Nagai, R. Tsuchiya, T. Mori, H. Tada, Y. Ichinose, and T. Koike A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J Thorac Cardiovasc Surg 125 2003 254 260
26. J.A. Roth, F. Fossella, R. Komaki, M.B. Ryan, J.B. Putnam Jr., and J.S. Lee A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86 1994 673 680
27. L. Voltolini, L. Luzzi, C. Ghiribelli, P. Paladini, M. Di Bisceglie, and G. Gotti Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy Eur J Cardiothorac Surg 20 2001 1106 1112
28. P. Therasse, E.A. Eisenhauer, and J. Verweij RECIST revisited: a review of validation studies on tumour assessment Eur J Cancer 42 2006 1031 1039
29. M.J. Krasna, Z. Gamliel, W.M. Burrows, J.R. Sonett, K.F. Kwong, and M.J. Edelman Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation Ann Thorac Surg 89 2010 200 206
30. Z. Mansour, E.A. Kochetkova, N. Santelmo, P. Meyer, J.M. Wihlm, and E. Quoix Risk factors for early mortality and morbidity after pneumonectomy: a reappraisal Ann Thorac Surg 88 2009 1737 1743